Blood-based gene expression signatures of infants and toddlers with autism

Stephen J Glatt, Ming T Tsuang, Mary Winn, Sharon D Chandler, Melanie Collins, Linda Lopez, Melanie Weinfeld, Cindy Carter, Nicholas Schork, Karen Pierce, Eric Courchesne, Stephen J Glatt, Ming T Tsuang, Mary Winn, Sharon D Chandler, Melanie Collins, Linda Lopez, Melanie Weinfeld, Cindy Carter, Nicholas Schork, Karen Pierce, Eric Courchesne

Abstract

Objective: Autism spectrum disorders (ASDs) are highly heritable neurodevelopmental disorders that onset clinically during the first years of life. ASD risk biomarkers expressed early in life could significantly impact diagnosis and treatment, but no transcriptome-wide biomarker classifiers derived from fresh blood samples from children with autism have yet emerged.

Method: Using a community-based, prospective, longitudinal method, we identified 60 infants and toddlers at risk for ASDs (autistic disorder and pervasive developmental disorder), 34 at-risk for language delay, 17 at-risk for global developmental delay, and 68 typically developing comparison children. Diagnoses were confirmed via longitudinal follow-up. Each child's mRNA expression profile in peripheral blood mononuclear cells was determined by microarray.

Results: Potential ASD biomarkers were discovered in one-half of the sample and used to build a classifier, with high diagnostic accuracy in the remaining half of the sample.

Conclusions: The mRNA expression abnormalities reliably observed in peripheral blood mononuclear cells, which are safely and easily assayed in infants, offer the first potential peripheral blood-based, early biomarker panel of risk for autism in infants and toddlers. Future work should verify these biomarkers and evaluate whether they may also serve as indirect indices of deviant molecular neural mechanisms in autism.

Copyright © 2012 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

References

    1. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009 Dec 18;58(10):1–20.
    1. Dawson G. Recent advances in research on early detection, causes, biology, and treatment of autism spectrum disorders. Curr Opin Neurol. 2010 Apr;23(2):95–96.
    1. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology. 2001 Nov 13;57(9):1618–1628.
    1. Chow ML, Pramparo T, Winn ME, et al. Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages. PLoS Genet. 2012 Mar;8(3):e1002592.
    1. Hu VW, Nguyen A, Kim KS, et al. Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS One. 2009;4(6):e5775.
    1. Baron CA, Liu SY, Hicks C, Gregg JP. Utilization of lymphoblastoid cell lines as a system for the molecular modeling of autism. J Autism Dev Disord. 2006 Nov;36(8):973–982.
    1. Nishimura Y, Martin CL, Vazquez-Lopez A, et al. Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet. 2007 Jul 15;16(14):1682–1698.
    1. Ghahramani Seno MM, Hu P, Gwadry FG, et al. Gene and miRNA expression profiles in autism spectrum disorders. Brain Res. 2011 Mar 22;1380:85–97.
    1. Kuwano Y, Kamio Y, Kawai T, et al. Autism-associated gene expression in peripheral leucocytes commonly observed between subjects with autism and healthy women having autistic children. PLoS One. 2011;6(9):e24723.
    1. Wetherby AM, Prizant BM. Communication and Symbolic Behavior Scales: Developmental Profile. 1st normed ed Paul H Brookes Publishing; Baltimore, MD, US: 2002.
    1. Wetherby AM, Allen L, Cleary J, Kublin K, Goldstein H. Validity and reliability of the communication and symbolic behavior scales developmental profile with very young children. J Speech Lang Hear Res. 2002 Dec;45(6):1202–1218.
    1. Pierce K, Carter C, Weinfeld M, et al. Detecting, Studying, and Treating Autism Early: The One-Year Well-Baby Check-Up Approach. J Pediatr. 2011 Apr 19;
    1. Lord C, Rutter M, DiLavore P, Risi S. Autism Diagnostic Observation Schedule (ADOS) manual. Western Psychological Services; Los Angeles, CA: 2001.
    1. Gotham K, Risi S, Pickles A, Lord C. The Autism Diagnostic Observation Schedule: revised algorithms for improved diagnostic validity. J Autism Dev Disord. 2007 Apr;37(4):613–627.
    1. Luyster R, Gotham K, Guthrie W, et al. The Autism Diagnostic Observation Schedule-toddler module: a new module of a standardized diagnostic measure for autism spectrum disorders. J Autism Dev Disord. 2009 Sep;39(9):1305–1320.
    1. Tager-Flusberg H, Cooper J. Present and future possibilities for defining a phenotype for specific language impairment. J Speech Lang Hear Res. 1999 Oct;42(5):1275–1278.
    1. Rapin I, Dunn M. Update on the language disorders of individuals on the autistic spectrum. Brain Dev. 2003 Apr;25(3):166–172.
    1. Tager-Flusberg H, Joseph RM. Identifying neurocognitive phenotypes in autism. Philos Trans R Soc Lond B Biol Sci. 2003 Feb 28;358(1430):303–314.
    1. Tager-Flusberg H, Skwerer DP, Joseph RM. Model syndromes for investigating social cognitive and affective neuroscience: a comparison of Autism and Williams syndrome. Soc Cogn Affect Neurosci. 2006 Dec;1(3):175–182.
    1. Glatt SJ, Everall IP, Kremen WS, et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(43):15533–15538.
    1. Schroeder A, Mueller O, Stocker S, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Molecular Biology. 2006;7:3.
    1. Dennis G, Jr, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biology. 2003;4(5):P3.
    1. Kohane IS, Valtchinov VI. Quantifying the white blood cell transcriptome as an accessible window to the multiorgan transcriptome. Bioinformatics. 2012 Feb 15;28(4):538–545.
    1. Tsuang MT, Nossova N, Yager T, et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):1–5.
    1. Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):261–268.
    1. Garbett K, Ebert PJ, Mitchell A, et al. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol. Dis. 2008 Jun;30(3):303–311.
    1. Karlovich C, Duchateau-Nguyen G, Johnson A, et al. A longitudinal study of gene expression in healthy individuals. BMC Med Genomics. 2009;2:33.
    1. McLoughlin K, Turteltaub K, Bankaitis-Davis D, et al. Limited dynamic range of immune response gene expression observed in healthy blood donors using RT-PCR. Mol Med. 2006 Jul-Aug;12(7–8):185–195.
    1. Campbell C, Vernon SD, Karem KL, Nisenbaum R, Unger ER. Assessment of normal variability in peripheral blood gene expression. Dis Markers. 2002;18(4):201–206.
    1. Eady JJ, Wortley GM, Wormstone YM, et al. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics. 2005 Aug 11;22(3):402–411.
    1. Radich JP, Mao M, Stepaniants S, et al. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics. 2004 Jun;83(6):980–988.
    1. Pierce K, Glatt SJ, Liptak GS, McIntyre LL. The power and promise of identifying autism early: insights from the search for clinical and biological markers. Annals of Clinical Psychiatry. 2009 Jul-Sep;21(3):132–147.

Source: PubMed

3
Tilaa